Green Cross Medical Science Corporation (142280) — Working Capital to Net Assets Ratio
Green Cross Medical Science Corporation (142280) has a Working Capital to Net Assets ratio of 11.6% as of December 2025. Working capital of ₩5.36 Billion (current assets of ₩40.75 Billion minus current liabilities of ₩35.39 Billion) is measured against net assets of ₩46.37 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Green Cross Medical Science Corporation (142280) net asset quality to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Green Cross Medical Science Corporation Working Capital to Net Assets (2014–2025)
This chart shows how Green Cross Medical Science Corporation's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2014 to 2025. As of December 2025, the ratio stands at 11.6%, reflecting working capital of ₩5.36 Billion against net assets of ₩46.37 Billion KRW. Check tangible equity quality of Green Cross Medical Science Corporation to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Green Cross Medical Science Corporation (2014–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Green Cross Medical Science Corporation from 2014 to 2025, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see how much is Green Cross Medical Science Corporation worth.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 11.6% | ₩5.36 Billion | ₩46.37 Billion | ₩40.75 Billion | ₩35.39 Billion | ▲ +6.0 pp |
| 2024 | 5.6% | ₩2.31 Billion | ₩41.21 Billion | ₩39.43 Billion | ₩37.12 Billion | ▲ +14.2 pp |
| 2023 | -8.6% | ₩-3.18 Billion | ₩36.92 Billion | ₩43.35 Billion | ₩46.53 Billion | ▼ -40.6 pp |
| 2022 | 32.0% | ₩10.65 Billion | ₩33.25 Billion | ₩50.14 Billion | ₩39.49 Billion | ▲ +22.4 pp |
| 2021 | 9.6% | ₩3.48 Billion | ₩36.11 Billion | ₩52.35 Billion | ₩48.87 Billion | ▼ -30.0 pp |
| 2020 | 39.7% | ₩22.39 Billion | ₩56.47 Billion | ₩61.49 Billion | ₩39.10 Billion | ▲ +0.3 pp |
| 2019 | 39.3% | ₩19.50 Billion | ₩49.58 Billion | ₩50.69 Billion | ₩31.19 Billion | ▼ -111.4 pp |
| 2018 | 150.7% | ₩23.12 Billion | ₩15.34 Billion | ₩44.86 Billion | ₩21.74 Billion | ▲ +90.5 pp |
| 2017 | 60.2% | ₩13.99 Billion | ₩23.23 Billion | ₩41.57 Billion | ₩27.58 Billion | ▲ +5.1 pp |
| 2016 | 55.2% | ₩14.81 Billion | ₩26.85 Billion | ₩41.39 Billion | ₩26.58 Billion | ▼ -3.4 pp |
| 2015 | 58.6% | ₩16.91 Billion | ₩28.87 Billion | ₩50.01 Billion | ₩33.10 Billion | ▼ -6.7 pp |
| 2014 | 65.2% | ₩20.55 Billion | ₩31.50 Billion | ₩39.82 Billion | ₩19.26 Billion | — |